Serigen receives the DBT-BIRAC-SBIRI grant funding

Yet another feather in the cap! Serigen (previously BiolMed) receives a Small Business Innovation Research Initiative (SBIRI) grant by Biotechnology Industry Research Assistance Council (BIRAC). This funding is for conducting pilot clinical investigations of our product Serioss. This will help us to establish safety of Serioss in humans.